Skip to main content
Equibles
BFNH logo

BFNH · Bioforce Nanosciences Holdings, Inc.

Track BFNH — free

Use BFNH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BFNH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$6.70 -0.05 (-0.74%) At close · Oct 20
Rebalance outlook locked
Going-concern doubt — flagged Aug 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company has reported recurring losses from operations and has net current liabilities and an accumulated deficit. These conditions raise substantial doubt as to the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 10, 2026
Market Cap
$225.11M
Shares
33.55M
Volume · Oct 20 3720 Avg daily vol (3M) 9767

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$6.70 Open$6.81 Day$6.57–6.89 52W close$0.18–10.01 Avg vol 30d12K Short int2K · 0.0% float · 1.0d Short vol24% DataJan 2020–Oct 2026 Filing10-Q · Aug 10

Up next

Latest filing: 10-Q
filed Aug 10, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$17,775
Trailing 12 months
Net income (TTM)
−$97,442
Trailing 12 months
Revenue growth YoY
+9.0%
Year over year
Operating margin
-261.8%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$307
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.1%
Year over year · more shares
Price change (1Y)
+717.1%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 17.3 · elevated Equity put/call 0.56
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +192%
above
Price vs 50-day avg +2%
above
RSI (14) 44
neutral
MACD trend Negative
52-week position 66%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return −33%
trailing
6-month return +1055%
trailing
YTD return +1055%
this year
Relative strength +1047%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $7 › 200d $2 — 50d above 200d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.01% of float · ▼ -67.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Squeeze score 26
low risk · 0–100
Fundamentals
Fair
Revenue growth +9%
Y/Y
Gross margin 25%
contracting
EPS growth −100%
Y/Y
Quant / Vol
risk profile
Very High
Volatility 447%
annualized · 1-yr
Max drawdown −86%
past year
ATR 16.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+192% Bullish
Price vs 50-day avg
+2% Bullish
RSI (14)
44 Neutral
MACD trend
Negative Bearish
52-week position
66% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50d $7 › 200d $2 — 50d above 200d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.01% of float · ▼ -67.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $7 · 66% Range high $10
vs 200-day avg +192% vs 50-day avg +2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Packaged Foods — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BFNH
Bioforce Nanosciences Holdings, Inc.
this stock
$225.11M +1055.2% +9.0% — 0.0%
JBS
Jbs N.V.
 $41.77B -11.9% — — 1.3%
KHC
Kraft Heinz Co
 $28.26B -1.7% -0.1% — 7.8%
GIS
General Mills Inc
 $17.87B -28.1% +4.1% — 7.7%
SJM
J M SMUCKER Co
 $13.57B +32.6% +3.7% — 4.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Falling
Shares short
2.3K
Days to cover
1.0d
Change
-4.8K sh
View
Short Volume
Short vol %
24%
As of
Oct 20, 2026
Short Total
View
Fails to Deliver
FTD shares
3.1K
Value
$28.7K
As of
Sep 21, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$17.8K
Net income (FY)
$-1.3M
EPS diluted
$-0.04
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 7, 2026
This year
12
View

Performance

5D 20D 120D MTD YTD
BFNH -10.2% -33.1% +1055.2% -16.3% +1055.2%
SPY -1.2% -0.6% +8.1% +0.8% +12.8%
vs SPY -9.0% -32.5% +1047.1% -17.1% +1042.4%
Key facts CIK 1310488 CUSIP 09064C206 Visit website Investor relations